Trials / Enrolling By Invitation
Enrolling By InvitationNCT05656664
Mitigation Efforts in Arsenic Exposure With Folic Acid Supplementation
Mitigation Efforts in Arsenic Exposure With Folic Acid Supplementation: Reducing Toxicity and Exploring the Impact on Lung Health
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University of Alabama at Birmingham · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effects on folic acid supplementation in a population living in an environment with chronic arsenic exposure in Birmingham, Alabama.
Detailed description
Folic acid supplementation effects urinary arsenic excretion. In this project investigators propose to investigate if oral folic acid dietary supplementation can increase urinary arsenic metabolite excretion
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Folic Acid | Folic acid supplementation to assess for increased arsenic metabolite excretion |
| OTHER | Placebo | Placebo group to assess arsenic metabolite excretion |
Timeline
- Start date
- 2023-09-14
- Primary completion
- 2025-12-31
- Completion
- 2026-12-31
- First posted
- 2022-12-19
- Last updated
- 2025-07-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05656664. Inclusion in this directory is not an endorsement.